<unk>  is an immunologic adjuvant that is FDA approved for the treatment of relapsing forms of multiple sclerosis.   Common adverse reactions include injection site reaction, lymphopenia, flu-like symptoms, myalgia, leukopenia, neutropenia, increased liver enzymes, headache, hypertonia, pain, rash, insomnia, abdominal pain, and asthenia.
Interferon beta-1b
Interferon beta-1a
Interferon type I
Interferon Alfa-n3
Interferon alfa-2b
Interferon alfa-2a
Peginterferon Beta-1a
Pegylated interferon-alpha-2a